Delivery Order 36F79719D0160-36C24524N0953
Award Date
9/23/24
Potential Completion Date
9/27/24
Potential Value
$19K
Federal Agency
Veterans Integrated Service Network 5
Awardee
Catalyst Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Veterans Integrated Service Network 20 (VISN 20), a component of the U.S. Department of Veterans Affairs (VA), to Catalyst Pharmaceuticals, Inc. The $132,865.82 firm fixed-price delivery order was placed against Catalyst's Federal Supply Schedule (FSS-61-IB) contract for the pharmaceutical product Amifampridine (Firdapse) 10mg Tablets, which is an FDA-approved treatment for Lambert-Eaton Myasthenic Syndrome (LEMS), a rare autoimmune disorder. The...
The Department of Veterans Affairs Veterans Health Administration awarded a $203,147 delivery order to Catalyst Pharmaceuticals, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. Catalyst Pharmaceuticals will supply AMIFAMPRIDINE FIRDAPSE 10MG tablets to various VA facilities in Veterans Integrated Service Network 20. Performance will take place in Bartlett, Tennessee over a one year base period from November 1, 2023 through October 31, 2024. Pricing is firm fixed. This...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,646 delivery order to Catalyst Pharmaceuticals, Inc. for amiFAMPRIDINE (FIRDAPSE) 10MG pharmaceutical products. The firm fixed price order was placed against Catalyst's Pharmaceuticals and Drugs schedule contract (FSS-61-IB) with no set-aside designation. The order is for delivery of the products to a location in Bartlett, Tennessee by September 16, 2022 to support VHA healthcare...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $34,394.25 delivery order to Catalyst Pharmaceuticals, Inc. for AMIFAMPRIDINE (FIRDAPSE) 10MG pharmaceutical products. The firm fixed price order was placed against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule master contract vehicle. Performance will take place in Bartlett, Tennessee through March 2023. No set-aside designation was applied to this order for FIRDAPSE, a...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,646 delivery order to Catalyst Pharmaceuticals, Inc. for AMIFAMPRIDINE (FIRDAPSE) 10MG. The firm fixed price order was placed against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule, with performance at a facility in Bartlett, Tennessee. No set-aside designation was used for this order to supply the anti-neuromuscular drug Firdapse to support VHA healthcare programs in the...
Catalyst Pharmaceuticals, Inc. was awarded a $29,691.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The firm fixed price order is for the delivery of amiFAMPRIDINE 10MG tablets to a location in Miami, Florida, with performance required by December 19, 2021. The order was placed off GSA Schedule FSS-61-IB, which provides pharmaceuticals and drugs to federal...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Anovorx Distribution LLC, a small business for-profit limited liability company, to provide the medication Firdapse (Amifampridine). The contract has a potential value of $151,359.02 and a completion date of September 19, 2019. Anovorx Distribution LLC has provided various specialty pharmaceutical products to the VA and Department of the Army Medical Command...
The Department of Veterans Affairs (VA) Veterans Health Administration and Veterans Integrated Service Network 12 awarded a firm fixed price delivery order contract to Acorda Therapeutics, Inc., a biotechnology company that develops drugs to improve therapies for neurological conditions. The $485,835.00 contract is for the delivery of DALFAMPRIDINE 10MG SA, a pharmaceutical product, with a completion date of July 14, 2017. The contract was issued off of the VA's Pharmaceuticals and Drugs Federal...
This federal contract award is a firm fixed-price delivery order issued by the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The contract, valued at $485,835.00, is for the supply of DALFAMPRIDINE 100 MG, a medication used to treat Parkinson's disease and multiple sclerosis symptoms. The contract was awarded on January 17, 2017, with a final completion date of...
This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in the development and commercialization of therapies for neurological disorders. The contract is for the supply of DALFAMPRIDINE, a medication used to treat Parkinson's disease and multiple sclerosis symptoms. The contract, valued at $478,860.00, is under the VA's Federal Supply Schedule 61-IB - Pharmaceuticals and Drugs....